If an (irresponsible) doctor has prescribed you any of these drugs, do not take them. | June 23, 2025

The message you’ve shared contains alarming claims about certain medications and the pharmaceutical industry. While it’s important to be aware of potential risks associated with medications, it’s equally critical to approach such information with caution and verify its accuracy. Here are some key points to consider:

1. Verify the Source

• The text mentions AFSSAPS (now ANSM, the French National Agency for Medicines Safety) and Prescrire magazine, a well-known independent drug bulletin. However, the tone and some claims (e.g., “soft and silent terrorism”) suggest bias or exaggeration.

• Always cross-check with official regulatory agencies like the FDA (U.S.), EMA (Europe), or ANSM (France) for up-to-date safety alerts.

2. Some Drugs Mentioned Have Known Risks (But Context Matters)

• Actos (pioglitazone): Linked to bladder cancer risk in long-term use, but still prescribed under careful monitoring in some countries.

• Avandia (rosiglitazone): Restricted or withdrawn in many countries due to cardiovascular risks, but this happened years ago (not recent news).

  Advertisement:

• Ketek (telithromycin): FDA restricted its use in 2007 due to liver toxicity.

• Zyprexa (olanzapine): Known for metabolic side effects (weight gain, diabetes) but remains a critical treatment for schizophrenia/bipolar disorder under supervision.

Many of these drugs are either already restricted or require strict risk-benefit evaluation by doctors.

3. Questionable Claims

• The text implies deliberate harm by pharmaceutical companies, which oversimplifies a complex system. While corporate misconduct has occurred (e.g., GSK’s $3 billion Avandia settlement), drugs are also rigorously tested and monitored.

  Advertisement:

• The comparison to “terrorism” is inflammatory and undermines legitimate critiques of drug safety.

4. What Should You Do?

• Do NOT stop prescribed medication abruptly without consulting your doctor. Sudden discontinuation can be dangerous.

• Research reputable sources: Check the FDA/EMA/ANSM websites or peer-reviewed journals (not just one article).

• Report side effects: If you experience adverse effects, notify your doctor and national pharmacovigilance system.

5. Pharmaceutical Industry Critiques: Valid but Nuanced

• The “17 ways” list echoes known issues (e.g., ghostwriting, lobbying), but not all companies engage in these practices.

  Advertisement:

• Reforms are ongoing (e.g., stricter transparency laws, clinical trial registries).

continued on next page

Advertisement: